Health Technology · Pharmaceuticals: Major · NSE: ONYX · data 2026-10-09
Onyx Biotec Ltd.
Health check: Weak (3.5/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹38
Market cap
₹68 cr
P/E
—
P/B
—
ROE
-0.4%
ROCE
0.5%
Debt / equity
0.27
Dividend yield
0.00%
1-year return
-7.3%
52-week high
₹49.65
52-week low
₹24.2
Operating margin
0.5%
Growth
| Revenue (last 12 months) | ₹69 cr |
| Net profit (last 12 months) | ₹-0 cr |
| Sales growth, 3 years (yearly) | 20.7% |
| Profit growth, 3 years (yearly) | — |
Similar companies
Vaishali Pharma Ltd. (VAISHALI) · Vilin Bio Med Ltd. (VILINBIO) · Sunil Healthcare Ltd. (SUNLOC) · Zenith Drugs Ltd. (ZENITHDRUG) · Vivimed Labs Limited (VIVIMEDLAB)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ONYX in NSE Scanner →